|

TOP STORIES
Geron's IND for Spinal Cord Injury Placed on Hold
Geron Corporation recently announced that its investigational new drug application for GRNOPC1, a cell therapy for neurologically complete, subacute spinal cord injury, has been placed on clinical hold by the FDA pending the agency's review of new nonclinical animal study data submitted by the company. [Geron, Menlo Park]

|
|
INDUSTRY NEWS
Connexon Creative Launches Cord Blood News
Cord Blood News is a weekly e-newsletter that keeps members of the cord blood community informed by providing the latest news from all areas of the field, including its science, research, policy, and business.
BioLife Solutions, Inc. and StemCell Technologies Inc. Announce Worldwide Distribution Agreement
BioLife Solutions, Inc. recently announced that it has entered into a non-exclusive distribution agreement with STEMCELL Technologies, Inc., a leading provider of products that support innovative research in hematology, immunology, cancer research, developmental biology, and many other areas of life science research. [StemCell Technologies, Vancouver]
Cryo-Cell Announces Strategic Partnership With S-Evans Biosciences, Inc.
Cryo-Cell International, Inc. recently announced that it has signed an exclusive license agreement with S-Evans Biosciences, Inc. to market and manufacture proprietary C`elle(SM) menstrual stem cell technology. [Cryo-Cell International, Inc., Oldsmar]
Salk Institute President to Join Stem Cell Board
Salk Institute President William Brody was appointed yesterday by Lt. Gov. John Garamendi to the oversight board for the state's stem cell institute. [Salk Institute, San Diego]
Biotechnology Industry is Expected to Rebound
Investors accurately forecasted the rebound of the biotechnology industry, but underestimated the degree to which positive clinical trial data would drive the sector higher, according to recent findings.
|
|
POLICY NEWS
Legislature to Duke It Out Over Stem Cell Regulations
Opponents of embryonic stem cell research in Michigan have mobilized to push for proposals requiring in-vitro fertilization patients to sign a consent form that addresses issues such as potential excess embryos, costs to store leftover embryos and a statement on the prohibition of accepting anything valuable in exchange for frozen embryos.
Francis S. Collins, M.D., Ph.D., Sworn in as NIH Director
Francis S. Collins, nominated to lead the NIH by President Barack Obama on July 8, was unanimously confirmed by the U.S. Senate on August 7.
New NIH chief: Turn Science into Better Care, Fast
In taking the reins of the NIH, Collins - best known for unraveling the human genetic code - said he wants a practical focus for the nation's premier research agency, that new discoveries may even help save precious health care dollars.
|
|
EVENTS
World Stem Cell Summit 2009
September 23-25, 2009
Baltimore, United States
TERMIS 2nd World Congress 2009
August 31 - September 3, 2009
Seoul, South Korea
Neuroscience 2009
October 17-21, 2009
Chicago, United States
Alzheimer's Disease Beyond Abeta
January 10-15, 2010
Copper Mountain, United States
Molecular Medicine Tri-Conference 2010
February 3-5, 2010
San Francisco, United States
ISSCR 8th Annual Meeting
June 16-19, 2010
San Francisco, United States
|
|
|
This email was sent by: Connexon Creative
400-570 W. 7th Avenue Vancouver, British Columbia V5Z 1B3 Canada |
|
|